Optimization of combined leukemia therapy by finite-dimensional optimal control modeling
From MaRDI portal
Publication:1682981
DOI10.1007/s10957-017-1161-9zbMath1386.49002OpenAlexW2754717830MaRDI QIDQ1682981
Svetlana Bunimovich-Mendrazitsky, Benzion Shklyar
Publication date: 6 December 2017
Published in: Journal of Optimization Theory and Applications (Search for Journal in Brave)
Full work available at URL: https://doi.org/10.1007/s10957-017-1161-9
Lua error in Module:PublicationMSCList at line 37: attempt to index local 'msc_result' (a nil value).
Related Items (3)
A quantitative study on the role of TKI combined with Wnt/\(\beta\)-catenin signaling and IFN-\(\alpha\) in the treatment of CML through deterministic and stochastic approaches ⋮ Progression, detection and remission: evolution of chronic myeloid leukemia using a three-stage probabilistic model ⋮ STABILITY ANALYSIS OF A MATHEMATICAL MODEL FOR CHRONIC MYELOID LEUKEMIA ERADICATION
Cites Work
- Unnamed Item
- Unnamed Item
- Unnamed Item
- Immunotherapy: an optimal control theory approach
- Stability and controllability issues in mathematical modeling of the intensive treatment of leukemia
- Delay-induced oscillatory dynamics of tumour-immune system interaction
- On optimal delivery of combination therapy for tumors
- Modeling immunotherapy of the tumor -- immune interaction
- Nonlinear dynamics of immunogenic tumors: Parameter estimation and global bifurcation analysis
- Optimal control applied to immunotherapy
- Tumour eradication by antiangiogenic therapy: analysis and extensions of the model by Hahnfeldt et al. (1999)
- Mathematical modelling of the use of macrophages as vehicles for drug delivery to hypoxic tumour sites
- A mathematical model for chronic myelogenous leukemia (CML) and T cell interaction
- Optimization of interleukin-21 immunotherapeutic strategies
- Optimal control analysis of a leukemia model under imatinib treatment
- Chemotherapy for tumors: An analysis of the dynamics and a study of quadratic and linear optimal controls
- Optimal control of treatment in a mathematical model of chronic myelogenous leukemia
- A general framework for modeling tumor-immune system competition and immunotherapy: Mathematical analysis and biomedical inferences
- Gradient Method for Finding Optimal Scheduling in Infinite Dimensional Models of Chemotherapy
- Optimal Control Applied to Cell-Cycle-Specific Cancer Chemotherapy
- TUMOR-IMMUNE SYSTEM INTERACTION: MODELING THE TUMOR-STIMULATED PROLIFERATION OF EFFECTORS AND IMMUNOTHERAPY
- Optimal control of innate immune response
This page was built for publication: Optimization of combined leukemia therapy by finite-dimensional optimal control modeling
